To view associated reagents, ancillaries and bulks, please visit the Roche Tissue Diagnostics reagent catalog.
The CINtec® Histology test is the only 510(k) p16 biomarker for clinical/IVD use in the evaluation of cervical biopsy specimens.
Does your p16 meet the defined criteria for Class II devices like CINtec Histology (p16)?
Be conclusive – diagnose with CINtec® Histology
Objectivity in cervical biopsy interpretation
When CINtec® Histology is used according to the LAST recommendations:
Be conclusive in diagnosing cervical pre-cancer using CINtec® Histology
CINtec® Histology enhances identification of occult lesions that may be missed by H&E or morphologic interpretation alone.
Agreement in diagnosis
The adjunctive use of CINtec® Histology helps pathologists ensure the right patient is treated without unnecessarily treating more patients.
The majority of pathologists using CINtec® Histology consistently identify 23% – 30% more high-grade cervical disease whether used on all biopsies or according to the LAST recommendations1.
Pathologists who use CINtec® Histology demonstrate improved diagnostic consistency and diagnostic agreement between each other and with expert gynecopathologists1.
19,250 CINtec® Histology slide interpretations by 70 individual surgical pathologists confirmed ≥99.1% acceptability for staining, morphology and background1.
CINtec® Histology provides objectivity to diagnostic interpretation that helps all pathologists identify more cervical disease.
CINtec Histology helps pathologist be even better at what they do!
In 100 women with disease:
CINtec® Histology finds 22.8% more high-grade disease1. These women can now be treated appropriately.
Use CINtec® Histology to put the spotlight on disease.